Keywords: fda, rejects, novartis, painkiller, prexige, food, drug

FDA rejects Novartis' painkiller Prexige

Article | 08 October 2007

Print This

The US Food and Drug Administration says that Swiss drug major Novartis' COX-2 inhibitor Prexige (lumiracoxib) is not approvable, based ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in